Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
22.29
+0.63 (2.91%)
At close: Jun 26, 2026, 4:00 PM EDT
22.57
+0.28 (1.26%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Monte Rosa Therapeutics Employees
Monte Rosa Therapeutics had 150 employees as of December 31, 2025. The number of employees increased by 16 or 11.94% compared to the previous year.
Employees
150
Change (1Y)
16
Growth (1Y)
11.94%
Revenue / Employee
$229,695
Profits / Employee
-$695,262
Market Cap
1.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 150 | 16 | 11.94% |
| Dec 31, 2024 | 134 | 1 | 0.75% |
| Dec 31, 2023 | 133 | 10 | 8.13% |
| Dec 31, 2022 | 123 | 30 | 32.26% |
| Dec 31, 2021 | 93 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Lakefront Biotherapeutics NV | 558 |
| Syndax Pharmaceuticals | 298 |
| Viridian Therapeutics | 252 |
| Zymeworks | 243 |
| Stoke Therapeutics | 170 |
| Taysha Gene Therapies | 99 |
| Tyra Biosciences | 87 |
GLUE News
- 23 days ago - Monte Rosa Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Monte Rosa Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 5 weeks ago - Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Monte Rosa Therapeutics price target raised to $31 from $30 at JPMorgan - TheFly
- 7 weeks ago - Monte Rosa Therapeutics reports Q1 revenue $4.21M, consensus $11.39M - TheFly
- 7 weeks ago - Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 7 weeks ago - Monte Rosa Therapeutics Earnings release: Q1 2026 - Filings